Liping Chang

机构：Hebei Medical University, Hebei University of Chinese Medicine, Changchun University of Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine · ORCID：0000-0002-8895-3337

发表论文 17 篇 · 总被引 375 次 · h-index 11

代表论文

• Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury (2020 · Theranostics · 被引 88)
• Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes <i>via</i> PI3K/AKT/GSK3β Signaling Pathway (2019 · Biological and Pharmaceutical Bulletin · 被引 53)
• Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1 (2017 · Frontiers in Pharmacology · 被引 45)
• Bazi Bushen mitigates epigenetic aging and extends healthspan in naturally aging mice (2023 · Biomedicine & Pharmacotherapy · 被引 42)
• miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway (2020 · Neoplasma · 被引 24)
• Tongxinluo Regulates Expression of Tight Junction Proteins and Alleviates Endothelial Cell Monolayer Hyperpermeability via ERK‐1/2 Signaling Pathway in Oxidized Low‐Density Lipoprotein‐Induced Human Umbilical Vein Endothelial Cells (2017 · Evidence-based Complementary and Alternative Medicine · 被引 22)